Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 2/2018

01-03-2018 | IM - REVIEW

Are too many inferior vena cava filters used? Controversial evidences in different clinical settings: a narrative review

Authors: Michele Dalla Vestra, Elisabetta Grolla, Luca Bonanni, Raffaele Pesavento

Published in: Internal and Emergency Medicine | Issue 2/2018

Login to get access

Abstract

The use of inferior vena cava filters to prevent pulmonary embolism is increasing mainly because of indications that appear to be unclearly codified and recommended. The evidence supporting this approach is often heterogeneous, and mainly based on observational studies and consensus opinions, while the insertion of an IVC filter exposes patients to the risk of complications and increases health care costs. Thus, several proposed indications for an IVC filter placement remain controversial. We attempt to review the proof on the efficacy and safety of IVC filters in several “special” clinical settings, and assess the robustness of the available evidence for any specific indication to place an IVC filter.
Literature
1.
Patel G, Panikkath R, Fenire M, Gadwala S, Nugent K (2015) Indications and appropriateness of inferior vena cava filter placement. Am J Med Sci 349:212–216CrossRefPubMed
2.
Spencer FA, Bates SM, Goldberg RJ, Lessard D, Emery C, Glushchenko A, Gore JM, White RH (2010) A population-based study of inferior vena cava filters in patients with acute venous thromboembolism. Arch Intern Med 170:1456–1462CrossRefPubMedPubMedCentral
3.
Stein PD, Kayali F, Olson RE (2004) Twenty-one-year trends in the use of inferior vena cava filters. Arch Intern Med 164:1541–1545CrossRefPubMed
4.
Duszak R Jr, Parker L, Levin DC, Rao VM (2011) Placement and removal of inferior vena cava filters: national trends in the medicare population. J Am Coll Radiol 8:483–489CrossRefPubMed
5.
Moore PS, Andrews JS, Craven TE, Davis RP, Corriere MA, Godshall CJ, Edwards MS, Hansen KJ (2010) Trends in vena caval interruption. J Vasc Surg 52:118–125 (discussion 125–6) CrossRefPubMed
6.
Stein PD, Matta F, Hull RD (2011) Increasing use of vena cava filters for prevention of pulmonary embolism. Am J Med 124:655–661CrossRefPubMed
7.
Baadh AS, Zikria JF, Rivoli S, Graham RE, Javit D, Ansell JE (2012) Indications for inferior vena cava filter placement: do physicians comply with guidelines? J Vasc Interv Radiol 23:989–995CrossRefPubMed
8.
Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, Laporte S, Faivre R, Charbonnier B, Barral FG, Huet Y, Simonneau G (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med 338:409–415CrossRefPubMed
9.
PREPIC Study Group (2005) Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d’Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 112:416–422CrossRef
10.
Mismetti P, Laporte S, Pellerin O, Ennezat PV, Couturaud F, Elias A, Falvo N, Meneveau N, Quere I, Roy PM, Sanchez O, Schmidt J, Seinturier C, Sevestre MA, Beregi JP, Tardy B, Lacroix P, Presles E, Leizorovicz A, Decousus H, Barral FG, Meyer G, PREPIC2 Study Group (2015) Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial. JAMA. 313:1627–1635CrossRefPubMed
11.
Stein PD, Matta F (2014) Vena cava filters in unstable elderly patients with acute pulmonary embolism. Am J Med 127:222–225CrossRefPubMed
12.
Muriel A, Jiménez D, Aujesky D, Bertoletti L, Decousus H, Laporte S, Mismetti P, Muñoz FJ, Yusen R, Monreal M, Investigators RIETE (2014) Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk. J Am Coll Cardiol 63:1675–1683CrossRefPubMed
13.
Milovanovic L, Kennedy SA, Midia M (2015) Procedural and indwelling complications with inferior vena cava filters: frequency, etiology, and management. Semin Interv Radiol 32:34–41CrossRef
14.
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR, American College of Chest Physicians (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e419S–e494SCrossRefPubMedPubMedCentral
15.
Kaufman JA, Kinney TB, Streiff MB, Sing RF, Proctor MC, Becker D, Cipolle M, Comerota AJ, Millward SF, Rogers FB, Sacks D, Venbrux AC (2006) Guidelines for the use of retrievable and convertible vena cava filters: report from the Society of Interventional Radiology multidisciplinary consensus conference. J Vasc Interv Radiol 17:449–459CrossRefPubMed
16.
Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, Jenkins JS, Kline JA, Michaels AD, Thistlethwaite P, Vedantham S, White RJ, Zierler BK, American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology (2011) Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 123:1788–1830CrossRefPubMed
17.
Crowley JJ, Hogan MJ, Towbin RB, Saad WE, Baskin KM, Marie Cahill A, Caplin DM, Connolly BL, Kalva SP, Krishnamurthy V, Marshalleck FE, Roebuck DJ, Saad NE, Salazar GM, Stokes LS, Temple MJ, Gregory Walker T, Nikolic B, Society of Interventional Radiology Standards of Practice Committee; Society for Pediatric Radiology Interventional Radiology Committee (2014) Quality improvement guidelines for pediatric gastrostomy and gastrojejunostomy tube placement. J Vasc Interv Radiol 25:1983–1991CrossRefPubMed
18.
19.
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JR, Wells P, Woller SC, Moores L (2016) Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 149:315–352CrossRefPubMed
20.
Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M, Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35(43):3033–3069CrossRefPubMed
21.
Imberti D, Dentali F, Ageno W, Crowther M, Garcia D, Huisman M, Rodeghiero F, D’Angelo A, Palareti G (2014) Evidence and clinical judgment: vena cava filters. Thromb Haemost 111:618–624CrossRefPubMed
22.
Velmahos GC, Kern J, Chan LS, Oder D, Murray JA, Shekelle P (2000) Prevention of venous thromboembolism after injury: an evidence-based report–part I: analysis of risk factors and evaluation of the role of vena caval filters. J Trauma 49:132–138 (discussion 139) CrossRefPubMed
23.
Girard TD, Philbrick JT, Fritz Angle J, Becker DM (2003) Prophylactic vena cava filters for trauma patients: a systematic review of the literature. Thromb Res 112:261–267CrossRefPubMed
24.
McMurtry AL, Owings JT, Anderson JT, Battistella FD, Gosselin R (1999) Increased use of prophylactic vena cava filters in trauma patients failed to decrease overall incidence of pulmonary embolism. J Am Coll Surg 189:314–320CrossRefPubMed
25.
Haut ER, Garcia LJ, Shihab HM, Brotman DJ, Stevens KA, Sharma R, Chelladurai Y, Akande TO, Shermock KM, Kebede S, Segal JB, Singh S (2014) The effectiveness of prophylactic inferior vena cava filters in trauma patients: a systematic review and meta-analysis. JAMA Surg 149:194–202CrossRefPubMed
26.
Hemmila MR, Osborne NH, Henke PK, Kepros JP, Patel SG, Cain-Nielsen AH, Birkmeyer NJ (2015) Prophylactic inferior vena cava filter placement does not result in a survival benefit for trauma patients. Ann Surg 262:577–585CrossRefPubMed
27.
Lavan O, Rimon U, Simon D, Khaitovich B, Segal B, Grossman E, Kleinbaum Y, Steinberg DM, Salomon O (2015) The use of optional inferior vena cava filters of type Optease in trauma patients-a single type of filter in a single Medical Center. Thromb Res 135:873–876CrossRefPubMed
28.
Coleman JJ, Zarzaur BL, Katona CW, Plummer ZJ, Johnson LS, Fecher A, O’Rear JM, Feliciano DV, Rozycki GS (2015) Factors associated with pulmonary embolism within 72 hours of admission after Trauma: a multicenter study. J Am Coll Surg 220:731–736CrossRefPubMed
29.
Ray CE Jr, Mitchell E, Zipser S, Kao EY, Brown CF, Moneta GL (2006) Outcomes with retrievable inferior vena cava filters: a multicenter study. J Vasc Interv Radiol 17:1595–1604CrossRefPubMed
30.
Gosin JS, Graham AM, Ciocca RG, Hammond JS (1997) Efficacy of prophylactic vena cava filters in high-risk trauma patients. Ann Vasc Surg 11:100–105CrossRefPubMed
31.
Karmy-Jones R, Jurkovich GJ, Velmahos GC, Burdick T, Spaniolas K, Todd SR, McNally M, Jacoby RC, Link D, Janczyk RJ, Ivascu FA, McCann M, Obeid F, Hoff WS, McQuay N Jr, Tieu BH, Schreiber MA, Nirula R, Brasel K, Dunn JA, Gambrell D, Huckfeldt R, Harper J, Schaffer KB, Tominaga GT, Vinces FY, Sperling D, Hoyt D, Coimbra R, Rosengart MR, Forsythe R, Cothren C, Moore EE, Haut ER, Hayanga AJ, Hird L, White C, Grossman J, Nagy K, Livaudais W, Wood R, Zengerink I, Kortbeek JB (2007) Practice patterns and outcomes of retrievable vena cava filters in trauma patients: an AAST multicenter study. J Trauma 62:17–24 (discussion 24–5) CrossRefPubMed
32.
Antevil JL, Sise MJ, Sack DI, Sasadeusz KJ, Swanson SM, Rivera L, Lome BR, Weingarten KE, Kaminski SS (2006) Retrievable vena cava filters for preventing pulmonary embolism in trauma patients: a cautionary tale. J Trauma 60:35–40CrossRefPubMed
33.
Maxwell RA, Chavarria-Aguilar M, Cockerham WT, Lewis PL, Barker DE, Durham RM, Ciraulo DL, Richart CM (2002) Routine prophylactic vena cava filtration is not indicated after acute spinal cord injury. J Trauma 52:902–906PubMed
34.
Ozturk C, Ganiyusufoglu K, Alanay A, Aydogan M, Onat L, Hamzaoglu A (2010) Efficacy of prophylactic placement of inferior vena cava filter in patients undergoing spinal surgery. Spine (Phila Pa 1976) 35:1893–1896CrossRef
35.
Leon L, Rodriguez H, Tawk RG, Ondra SL, Labropoulos N, Morasch MD (2005) The prophylactic use of inferior vena cava filters in patients undergoing high-risk spinal surgery. Ann Vasc Surg 19:442–447CrossRefPubMed
36.
Ghanim AJ, Daskalakis C, Eschelman DJ, Kraft WK (2007) A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants. J Thromb Thrombol 24:247–254CrossRef
37.
Shapiro SA, White IK (2016) 346 Temporary Inferior vena cava filter to prevent pulmonary embolism in thrombophilic neurosurgery patients. Neurosurgery 63(Supp 1):202CrossRefPubMed
38.
Sapala JA, Wood MH, Schuhknecht MP, Sapala MA (2003) Fatal pulmonary embolism after bariatric operations for morbid obesity: a 24-year retrospective analysis. Obes Surg 13:819–825CrossRefPubMed
39.
Rutherford RB (2005) Prophylactic indications for vena cava filters: critical appraisal. Semin Vasc Surg 18:158–165CrossRefPubMed
40.
Gargiulo NJ 3rd, Veith FJ, Lipsitz EC, Suggs WD, Ohki T, Goodman E (2006) Experience with inferior vena cava filter placement in patients undergoing open gastric bypass procedures. J Vasc Surg 44:1301–1305CrossRefPubMed
41.
Halmi D, Kolesnikov E (2007) Preoperative placement of retreivable inferior vena cava filters in bariatric surgery. Surg Obes Relat Dis 3:602–605CrossRefPubMed
42.
Overby DW, Kohn GP, Cahan MA, Dixon RG, Stavas JM, Moll S, Burke CT, Colton KJ, Farrell TM (2009) Risk-group targeted inferior vena cava filter placement in gastric bypass patients. Obes Surg 19:451–455CrossRefPubMed
43.
Birkmeyer NJ, Share D, Baser O, Carlin AM, Finks JF, Pesta CM, Genaw JA, Birkmeyer JD, Michigan Bariatric Surgery Collaborative (2010) Preoperative placement of inferior vena cava filters and outcomes after gastric bypass surgery. Ann Surg 252:313–318CrossRefPubMed
44.
Birkmeyer NJ, Finks JF, English WJ, Carlin AM, Hawasli AA, Genaw JA, Wood MH, Share DA, Birkmeyer JD, Michigan Bariatric Surgery Collaborative (2013) Risks and benefits of prophylactic inferior vena cava filters in patients undergoing bariatric surgery. J Hosp Med 8:173–177CrossRefPubMed
45.
Rowland SP, Dharmarajah B, Moore HM, Lane TR, Cousins J, Ahmed AR, Davies AH (2015) Inferior vena cava filters for prevention of venous thromboembolism in obese patients undergoing bariatric surgery: a systematic review. Ann Surg 261:35–45CrossRefPubMed
46.
Rajasekhar A, Crowther M (2010) Inferior vena caval filter insertion prior to bariatric surgery: a systematic review of the literature. J Thromb Haemost 8:1266–1270CrossRefPubMed
47.
Brotman DJ, Shihab HM, Prakasa KR, Kebede S, Haut ER, Sharma R, Shermock K, Chelladurai Y, Singh S, Segal JB (2013) Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery: a systematic review and meta-analysis. JAMA Surg 148:675–686CrossRefPubMed
48.
Kaw R, Pasupuleti V, Wayne Overby D, Deshpande A, Coleman CI, Ioannidis JP, Hernandez AV (2014) Inferior vena cava filters and postoperative outcomes in patients undergoing bariatric surgery: a meta-analysis. Surg Obes Relat Dis. 10(4):725–733 (Cardiovascular Meta-analysis Research Group) CrossRefPubMed
49.
Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, Marchiori A, Sabbion P, Prins MH, Noventa F, Girolami A (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100:3484–3488CrossRefPubMed
50.
Wallace MJ, Jean JL, Gupta S, Eapen GA, Johnson MM, Ahrar K, Madoff DC, Morello FA, Murthy R, Hicks ME (2004) Use of inferior vena caval filters and survival in patients with malignancy. Cancer 101:1902–1907CrossRefPubMed
51.
Jarrett BP, Dougherty MJ, Calligaro KD (2002) Inferior vena cava filters in malignant disease. J Vasc Surg 36:704–707CrossRefPubMed
52.
Stein PD, Matta F, Sabra MJ (2013) Case fatality rate with vena cava filters in hospitalized stable patients with cancer and pulmonary embolism. Am J Med 126:819–824CrossRefPubMed
53.
Noble SI, Shelley MD, Coles B, Williams SM, Wilcock A, Johnson MJ, Association for Palliative Medicine for Great Britain and Ireland (2008) Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis. Lancet Oncol 9:577–584CrossRefPubMed
54.
Whitney BA, Kerstein MD (1987) Thrombocytopenia and cancer: use of the Kim-Ray Greenfield filter to prevent thromboembolism. South Med J 80:1246–1248CrossRefPubMed
55.
Barginear MF, Lesser M, Akerman ML, Strakhan M, Shapira I, Bradley T, Budman DR (2009) Need for inferior vena cava filters in cancer patients: a surrogate marker for poor outcome. Clin Appl Thromb Hemost 15:263–269CrossRefPubMed
56.
Schunn C, Schunn GB, Hobbs G, Vona-Davis LC, Waheed U (2006) Inferior vena cava filter placement in late-stage cancer. Vasc Endovasc Surg 40:287–294CrossRef
57.
Rosenberger P, Shernan SK, Rawn JD, Scott J, Eltzschig HK (2005) Critical role of inferior vena caval filter placement after pulmonary embolectomy. J Card Surg 20(3):289–290CrossRefPubMed
58.
Streiff MB (2000) Vena caval filters: a comprehensive review. Blood 95:3669–3677PubMed
59.
Norris CS, Greenfield LJ, Herrmann JB (1985) Free-floating iliofemoral thrombus. A risk of pulmonary embolism. Arch Surg 120:806–808CrossRefPubMed
60.
Pacouret G, Alison D, Pottier JM, Bertrand P, Charbonnier B (1997) Free-floating thrombus and embolic risk in patients with angiographically confirmed proximal deep venous thrombosis. A prospective study. Arch Intern Med 157:305–308CrossRefPubMed
61.
Avgerinos ED, Hager ES, Jeyabalan G, Marone L, Makaroun MS, Chaer RA (2014) Inferior vena cava filter placement during thrombolysis for acute iliofemoral deep venous thrombosis. J Vasc Surg Venous Lymphat Disord 2:274–281CrossRefPubMed
62.
Yamagami T, Kato T, Hirota T, Yoshimatsu R, Matsumoto T, Nishimura T (2006) Prophylactic implantation of inferior vena cava filter during interventional radiological treatment for deep venous thrombosis of the lower extremity. Br J Radiol 79:584–591CrossRefPubMed
63.
Sharifi M, Bay C, Skrocki L, Lawson D, Mazdeh S (2012) Role of IVC filters in endovenous therapy for deep venous thrombosis: the FILTER-PEVI (filter implantation to lower thromboembolic risk in percutaneous endovenous intervention) trial. Cardiovasc Interv Radiol 35:1408–1413CrossRef
64.
Théry C, Bauchart JJ, Lesenne M, Asseman P, Flajollet JG, Legghe R, Marache P (1992) Predictive factors of effectiveness of streptokinase in deep venous thrombosis. Am J Cardiol 69:117–122CrossRefPubMed
65.
Mismetti P, Rivron-Guillot K, Quenet S, Décousus H, Laporte S, Epinat M, Barral FG (2007) A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism. Chest 131:223–229CrossRefPubMed
66.
Hajduk B, Tomkowski WZ, Malek G, Davidson BL (2010) Vena cava filter occlusion and venous thromboembolism risk in persistently anticoagulated patients: a prospective, observational cohort study. Chest 137:877–882CrossRefPubMed
67.
Grande WJ, Trerotola SO, Reilly PM, Clark TW, Soulen MC, Patel A, Shlansky-Goldberg RD, Tuite CM, Solomon JA, Mondschein JI, Fitzpatrick MK, Stavropoulos SW (2009) Experience with the recovery filter as a retrievable inferior vena cava filter. J Vasc Interv Radiol 16:1189–1193CrossRef
68.
Smoot RL, Koch CA, Heller SF, Sabater EA, Cullinane DC, Bannon MP, Thomsen KM, Harmsen WS, Baerga-Varela Y, Schiller HJ (2010) Inferior vena cava filters in trauma patients: efficacy, morbidity, and retrievability. J Trauma 68:899–903CrossRefPubMed
69.
70.
Angel LF, Tapson V, Galgon RE, Restrepo MI, Kaufman J (2011) Systematic review of the use of retrievable inferior vena cava filters. J Vasc Interv Radiol 22(1522–1530):e3
71.
Rottenstreich A, Spectre G, Roth B, Bloom AI, Kalish Y (2015) Patterns of use and outcome of Inferior vena cava (IVC) filters in a tertiary care setting. Eur J Haematol. doi:10.​1111/​ejh.​12542 PubMed
72.
Sarosiek S, Crowther M, Sloan JM (2013) Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma center. JAMA Intern Med 173:513–517CrossRefPubMed
Metadata
Title
Are too many inferior vena cava filters used? Controversial evidences in different clinical settings: a narrative review
Authors
Michele Dalla Vestra
Elisabetta Grolla
Luca Bonanni
Raffaele Pesavento
Publication date
01-03-2018
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 2/2018
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-016-1575-7

Other articles of this Issue 2/2018

Internal and Emergency Medicine 2/2018 Go to the issue

IM - ORIGINAL

Predictive modeling of inpatient mortality in departments of internal medicine

IM - COMMENTARY

Inferior vena cava filters: use or abuse?

IM - COMMENTARY

Oxidative stress management during non-invasive ventilation in acute respiratory failure

EM - ORIGINAL

Impact of red blood cell transfusion on acute coronary syndrome: a meta-analysis

CE - LETTER TO THE EDITOR

Medical doctors and the foundation of the International Red Cross

EM - ORIGINAL

Novel ECG changes in acute coronary syndromes. Would improvement in the recognition of ‘STEMI-equivalents’ affect time until reperfusion?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits